Edition:
India

People: Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

25.38USD
1:30am IST
Change (% chg)

$0.35 (+1.40%)
Prev Close
$25.03
Open
$24.98
Day's High
$25.60
Day's Low
$24.74
Volume
14,378
Avg. Vol
16,687
52-wk High
$38.48
52-wk Low
$19.43

Klibanski, Anne 

Dr. Anne Klibanski M.D. is the Independent Director of Albireo Pharma Inc. Dr. Klibanski has served as a member of our board of directors since June 2018. Dr. Klibanski has served as Chief Academic Officer of Partners HealthCare since March 2012, where she oversees Partners-wide academic programs in research and education. In February 2019, Dr. Klibanski was named interim President and Chief Executive Officer of Partners HealthCare. Dr. Klibanski has also served as Chief, Neuroendocrine Unit at Massachusetts General Hospital since 1989 and as the Laurie Carrol Guthart Professor of Medicine at Harvard Medical School since 2009. She is a leader in the field of neuroendocrine disorders and pituitary tumors. The author of over 350 papers and chapters, she has received numerous awards, including the Endocrine Society Clinical Investigator Award and the Clinical Endocrinology Trust Medal from the British Endocrine Society and has served as a member of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Board of Counselors. Dr. Klibanski holds a B.A. from Barnard College and an M.D. from New York University School of Medicine.

Basic Compensation

Total Annual Compensation, USD 21,823
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 371,025
Fiscal Year Total, USD 392,848

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Chiswell

195,084

Ronald Cooper

3,618,630

Simon Harford

--

Jan Mattsson

1,404,280

Martha Carter

1,243,480

Patrick Horn

--
As Of  31 Dec 2018